Kovina Therapeutics
About:
Kovina Therapeutics operates as a pre-clinical biotechnology company.
Website: https://www.kovina.com/
Top Investors: National Institute of Allergy and Infectious Diseases, National Cancer Institute, BioCrossroads, Elevate Ventures, IU Ventures
Description:
Kovina Therapeutics operates as a pre-clinical biotechnology company aims to discover a non-surgical, medical treatment for Human Papillomavirus (HPV) infections and cancers.
Total Funding Amount:
$2.58M
Headquarters Location:
Indianapolis, Indiana, United States
Founded Date:
2020-01-01
Founders:
Elliot Androphy, Samy Meroueh, Zhijian Lu
Number of Employees:
11-50
Last Funding Date:
2022-11-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai